Tilray Brands, Inc. (TLRY.TO)
CAD 1.69
(-3.98%)
CAD 1.69
(-3.98%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 387.31 Million USD | -34.37% |
| 2022 | 590.13 Million USD | -5.4% |
| 2021 | 623.8 Million USD | -33.54% |
| 2020 | 938.65 Million USD | 212.55% |
| 2019 | 300.32 Million USD | -16.84% |
| 2018 | 361.11 Million USD | 1397.9% |
| 2017 | 24.1 Million USD | -2.84% |
| 2016 | 24.81 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - CAD | -100.0% |
| 2012 | 619.36 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 322.12 Million USD | -4.65% |
| 2023 FY | 387.31 Million USD | -34.37% |
| 2023 Q4 | 387.31 Million USD | -19.58% |
| 2023 Q3 | 481.61 Million USD | -9.02% |
| 2023 Q2 | 529.38 Million USD | -5.92% |
| 2023 Q1 | 562.71 Million USD | -4.65% |
| 2022 Q4 | 590.13 Million USD | -2.25% |
| 2022 FY | 590.13 Million USD | -5.4% |
| 2022 Q1 | 657.81 Million USD | 5.45% |
| 2022 Q2 | 608.91 Million USD | -7.43% |
| 2022 Q3 | 603.73 Million USD | -0.85% |
| 2021 Q2 | 799.77 Million USD | -8.47% |
| 2021 Q1 | 873.73 Million USD | -6.92% |
| 2021 Q4 | 623.8 Million USD | -14.88% |
| 2021 Q3 | 732.87 Million USD | -8.37% |
| 2021 FY | 623.8 Million USD | -33.54% |
| 2020 Q3 | 728.8 Million USD | 72.83% |
| 2020 Q2 | 421.68 Million USD | 29.9% |
| 2020 Q1 | 324.62 Million USD | 8.09% |
| 2020 FY | 938.65 Million USD | 212.55% |
| 2020 Q4 | 938.65 Million USD | 28.79% |
| 2019 FY | 300.32 Million USD | -16.84% |
| 2019 Q1 | 354.66 Million USD | -1.79% |
| 2019 Q3 | 362.1 Million USD | -4.8% |
| 2019 Q2 | 380.37 Million USD | 7.25% |
| 2019 Q4 | 300.32 Million USD | -17.06% |
| 2018 FY | 361.11 Million USD | 1397.9% |
| 2018 Q4 | 361.11 Million USD | 513.53% |
| 2018 Q3 | 58.85 Million USD | 41.69% |
| 2018 Q2 | 41.54 Million USD | -3.57% |
| 2018 Q1 | 43.07 Million USD | 78.69% |
| 2017 Q3 | 30.26 Million USD | 19.54% |
| 2017 Q4 | 24.1 Million USD | -20.34% |
| 2017 FY | 24.1 Million USD | -2.84% |
| 2017 Q1 | 26.1 Million USD | 5.2% |
| 2017 Q2 | 25.31 Million USD | -3.01% |
| 2016 FY | 24.81 Million USD | 0.0% |
| 2016 Q4 | 24.81 Million USD | 272.38% |
| 2016 Q3 | 6.66 Million USD | 18.59% |
| 2016 Q1 | 5.9 Million USD | 0.0% |
| 2016 Q2 | 5.61 Million USD | -4.8% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q1 | 90.78 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - CAD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 FY | 619.36 Thousand USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | -269.609% |
| Avicanna Inc. | 1.8 Million CAD | -21377.079% |
| Avant Brands Inc. | 18.7 Million CAD | -1970.992% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -244214.712% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -30786.523% |
| Knight Therapeutics Inc. | 69.09 Million CAD | -460.59% |
| MediPharm Labs Corp. | 2.29 Million CAD | -16776.558% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -249781.935% |
| Canopy Growth Corporation | 683.17 Million CAD | 43.306% |
| Willow Biosciences Inc. | 2.15 Million CAD | -17864.61% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | -143.527% |